nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—blood plasma—Creutzfeldt-Jakob disease	0.0781	0.0869	CbGeAlD
Carvedilol—SELE—blood plasma—Creutzfeldt-Jakob disease	0.0527	0.0587	CbGeAlD
Carvedilol—VCAM1—blood plasma—Creutzfeldt-Jakob disease	0.0485	0.054	CbGeAlD
Carvedilol—NPPB—lymphoid tissue—Creutzfeldt-Jakob disease	0.0304	0.0338	CbGeAlD
Carvedilol—HIF1A—brainstem—Creutzfeldt-Jakob disease	0.0265	0.0295	CbGeAlD
Carvedilol—GJA1—brainstem—Creutzfeldt-Jakob disease	0.0257	0.0286	CbGeAlD
Carvedilol—NPPB—central nervous system—Creutzfeldt-Jakob disease	0.0223	0.0249	CbGeAlD
Carvedilol—SELE—lymphoid tissue—Creutzfeldt-Jakob disease	0.0205	0.0229	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0189	0.021	CbGeAlD
Carvedilol—SELE—spinal cord—Creutzfeldt-Jakob disease	0.0186	0.0207	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—Creutzfeldt-Jakob disease	0.0182	0.0202	CbGeAlD
Carvedilol—NPPB—brain—Creutzfeldt-Jakob disease	0.0177	0.0198	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0176	0.0196	CbGeAlD
Carvedilol—VCAM1—spinal cord—Creutzfeldt-Jakob disease	0.0171	0.0191	CbGeAlD
Carvedilol—HIF1A—spinal cord—Creutzfeldt-Jakob disease	0.0165	0.0183	CbGeAlD
Carvedilol—GJA1—spinal cord—Creutzfeldt-Jakob disease	0.016	0.0178	CbGeAlD
Carvedilol—NDUFC2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0153	0.0171	CbGeAlD
Carvedilol—SELE—central nervous system—Creutzfeldt-Jakob disease	0.0151	0.0168	CbGeAlD
Carvedilol—HIF1A—Circadian Clock—NPAS2—Creutzfeldt-Jakob disease	0.0149	0.146	CbGpPWpGaD
Carvedilol—SELE—cerebellum—Creutzfeldt-Jakob disease	0.0148	0.0164	CbGeAlD
Carvedilol—NDUFC2—spinal cord—Creutzfeldt-Jakob disease	0.0139	0.0155	CbGeAlD
Carvedilol—VCAM1—central nervous system—Creutzfeldt-Jakob disease	0.0139	0.0155	CbGeAlD
Carvedilol—HIF1A—central nervous system—Creutzfeldt-Jakob disease	0.0134	0.0149	CbGeAlD
Carvedilol—HIF1A—cerebellum—Creutzfeldt-Jakob disease	0.0131	0.0145	CbGeAlD
Carvedilol—GJA1—central nervous system—Creutzfeldt-Jakob disease	0.013	0.0144	CbGeAlD
Carvedilol—GJA1—cerebellum—Creutzfeldt-Jakob disease	0.0127	0.0141	CbGeAlD
Carvedilol—VEGFA—spinal cord—Creutzfeldt-Jakob disease	0.0126	0.014	CbGeAlD
Carvedilol—SELE—brain—Creutzfeldt-Jakob disease	0.012	0.0133	CbGeAlD
Carvedilol—NDUFC2—central nervous system—Creutzfeldt-Jakob disease	0.0113	0.0126	CbGeAlD
Carvedilol—CYP1A2—blood plasma—Creutzfeldt-Jakob disease	0.0111	0.0124	CbGeAlD
Carvedilol—NDUFC2—cerebellum—Creutzfeldt-Jakob disease	0.011	0.0123	CbGeAlD
Carvedilol—VCAM1—brain—Creutzfeldt-Jakob disease	0.011	0.0123	CbGeAlD
Carvedilol—HIF1A—brain—Creutzfeldt-Jakob disease	0.0106	0.0118	CbGeAlD
Carvedilol—CYP2C9—blood plasma—Creutzfeldt-Jakob disease	0.0105	0.0117	CbGeAlD
Carvedilol—GJA1—brain—Creutzfeldt-Jakob disease	0.0103	0.0115	CbGeAlD
Carvedilol—ADRA2A—blood plasma—Creutzfeldt-Jakob disease	0.0102	0.0114	CbGeAlD
Carvedilol—VEGFA—cerebellum—Creutzfeldt-Jakob disease	0.01	0.0111	CbGeAlD
Carvedilol—CYP2E1—blood plasma—Creutzfeldt-Jakob disease	0.00998	0.0111	CbGeAlD
Carvedilol—VCAM1—Alpha4 beta1 integrin signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00967	0.0948	CbGpPWpGaD
Carvedilol—PTGS1—blood plasma—Creutzfeldt-Jakob disease	0.00961	0.0107	CbGeAlD
Carvedilol—NDUFC2—brain—Creutzfeldt-Jakob disease	0.00896	0.00997	CbGeAlD
Carvedilol—VEGFA—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00859	0.0842	CbGpPWpGaD
Carvedilol—VEGFA—brain—Creutzfeldt-Jakob disease	0.00813	0.00905	CbGeAlD
Carvedilol—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00803	0.00894	CbGeAlD
Carvedilol—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.0079	0.0088	CbGeAlD
Carvedilol—ADRA1A—brainstem—Creutzfeldt-Jakob disease	0.00761	0.00848	CbGeAlD
Carvedilol—ADRA1B—central nervous system—Creutzfeldt-Jakob disease	0.00684	0.00761	CbGeAlD
Carvedilol—ADRA1D—central nervous system—Creutzfeldt-Jakob disease	0.00669	0.00745	CbGeAlD
Carvedilol—VCAM1—Interferon gamma signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00604	0.0592	CbGpPWpGaD
Carvedilol—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00568	0.00633	CbGeAlD
Carvedilol—ADRA1B—brain—Creutzfeldt-Jakob disease	0.00543	0.00604	CbGeAlD
Carvedilol—ADRA1D—brain—Creutzfeldt-Jakob disease	0.00531	0.00591	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—Creutzfeldt-Jakob disease	0.00522	0.00581	CbGeAlD
Carvedilol—ADRB1—central nervous system—Creutzfeldt-Jakob disease	0.00486	0.00541	CbGeAlD
Carvedilol—KCNH2—spinal cord—Creutzfeldt-Jakob disease	0.00457	0.00509	CbGeAlD
Carvedilol—ADRA2C—spinal cord—Creutzfeldt-Jakob disease	0.00451	0.00502	CbGeAlD
Carvedilol—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00448	0.00499	CbGeAlD
Carvedilol—CYP2E1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00388	0.00433	CbGeAlD
Carvedilol—ADRB1—brain—Creutzfeldt-Jakob disease	0.00386	0.00429	CbGeAlD
Carvedilol—ADRA1A—central nervous system—Creutzfeldt-Jakob disease	0.00384	0.00428	CbGeAlD
Carvedilol—ADRA1A—cerebellum—Creutzfeldt-Jakob disease	0.00375	0.00418	CbGeAlD
Carvedilol—KCNH2—central nervous system—Creutzfeldt-Jakob disease	0.00371	0.00413	CbGeAlD
Carvedilol—ADRA2C—central nervous system—Creutzfeldt-Jakob disease	0.00366	0.00408	CbGeAlD
Carvedilol—KCNH2—cerebellum—Creutzfeldt-Jakob disease	0.00363	0.00404	CbGeAlD
Carvedilol—ADRA2A—spinal cord—Creutzfeldt-Jakob disease	0.0036	0.00401	CbGeAlD
Carvedilol—ADRA2C—cerebellum—Creutzfeldt-Jakob disease	0.00358	0.00398	CbGeAlD
Carvedilol—CYP2E1—spinal cord—Creutzfeldt-Jakob disease	0.00352	0.00392	CbGeAlD
Carvedilol—PTGS1—spinal cord—Creutzfeldt-Jakob disease	0.00339	0.00378	CbGeAlD
Carvedilol—CYP1A1—central nervous system—Creutzfeldt-Jakob disease	0.00313	0.00349	CbGeAlD
Carvedilol—ADRA1A—brain—Creutzfeldt-Jakob disease	0.00305	0.0034	CbGeAlD
Carvedilol—VCAM1—Interferon Signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00295	0.0289	CbGpPWpGaD
Carvedilol—KCNH2—brain—Creutzfeldt-Jakob disease	0.00294	0.00328	CbGeAlD
Carvedilol—ADRA2A—central nervous system—Creutzfeldt-Jakob disease	0.00292	0.00325	CbGeAlD
Carvedilol—ADRA2C—brain—Creutzfeldt-Jakob disease	0.00291	0.00324	CbGeAlD
Carvedilol—VCAM1—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.0029	0.0284	CbGpPWpGaD
Carvedilol—CYP2E1—central nervous system—Creutzfeldt-Jakob disease	0.00286	0.00318	CbGeAlD
Carvedilol—ADRA2A—cerebellum—Creutzfeldt-Jakob disease	0.00285	0.00318	CbGeAlD
Carvedilol—CYP2E1—cerebellum—Creutzfeldt-Jakob disease	0.00279	0.00311	CbGeAlD
Carvedilol—PTGS1—central nervous system—Creutzfeldt-Jakob disease	0.00275	0.00306	CbGeAlD
Carvedilol—GJA1—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.00266	0.0261	CbGpPWpGaD
Carvedilol—GJA1—Myometrial Relaxation and Contraction Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00258	0.0253	CbGpPWpGaD
Carvedilol—GJA1—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00256	0.0251	CbGpPWpGaD
Carvedilol—CYP1A1—brain—Creutzfeldt-Jakob disease	0.00249	0.00277	CbGeAlD
Carvedilol—HIF1A—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00247	0.0242	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00241	0.0236	CbGpPWpGaD
Carvedilol—ADRA2A—brain—Creutzfeldt-Jakob disease	0.00232	0.00258	CbGeAlD
Carvedilol—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.0023	0.00256	CbGeAlD
Carvedilol—CYP2E1—brain—Creutzfeldt-Jakob disease	0.00227	0.00253	CbGeAlD
Carvedilol—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.00226	0.00252	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00221	0.00246	CbGeAlD
Carvedilol—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.00221	0.00246	CbGeAlD
Carvedilol—GJA1—Membrane Trafficking—YWHAZ—Creutzfeldt-Jakob disease	0.00219	0.0215	CbGpPWpGaD
Carvedilol—PTGS1—brain—Creutzfeldt-Jakob disease	0.00218	0.00243	CbGeAlD
Carvedilol—VEGFA—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00207	0.0203	CbGpPWpGaD
Carvedilol—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00201	0.00223	CbGeAlD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00197	0.0193	CbGpPWpGaD
Carvedilol—CYP2D6—brain—Creutzfeldt-Jakob disease	0.0018	0.002	CbGeAlD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00175	0.0171	CbGpPWpGaD
Carvedilol—SELE—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00165	0.0162	CbGpPWpGaD
Carvedilol—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.00163	0.00181	CbGeAlD
Carvedilol—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.00159	0.00177	CbGeAlD
Carvedilol—VCAM1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00149	0.0146	CbGpPWpGaD
Carvedilol—CYP1A1—PPARA activates gene expression—NPAS2—Creutzfeldt-Jakob disease	0.00143	0.014	CbGpPWpGaD
Carvedilol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NPAS2—Creutzfeldt-Jakob disease	0.0014	0.0137	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00133	0.013	CbGpPWpGaD
Carvedilol—ABCB1—brain—Creutzfeldt-Jakob disease	0.00129	0.00144	CbGeAlD
Carvedilol—VEGFA—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00114	0.0112	CbGpPWpGaD
Carvedilol—ADRB3—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.00111	0.0109	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00107	0.0105	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00106	0.0104	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000988	0.00968	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000968	0.00949	CbGpPWpGaD
Carvedilol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000966	0.00947	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000941	0.00922	CbGpPWpGaD
Carvedilol—XDH—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00094	0.00921	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000902	0.00884	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000815	0.00798	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000808	0.00792	CbGpPWpGaD
Carvedilol—ADRA1D—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.000723	0.00708	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000696	0.00682	CbGpPWpGaD
Carvedilol—ADRB1—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.000659	0.00645	CbGpPWpGaD
Carvedilol—ADRB2—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.000644	0.00631	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000643	0.0063	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000641	0.00628	CbGpPWpGaD
Carvedilol—ADRA1B—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.0006	0.00588	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000571	0.00559	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000546	0.00535	CbGpPWpGaD
Carvedilol—ADRA1A—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.000533	0.00522	CbGpPWpGaD
Carvedilol—XDH—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000519	0.00509	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000519	0.00509	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000476	0.00466	CbGpPWpGaD
Carvedilol—HIF1A—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000467	0.00458	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000445	0.00436	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000444	0.00435	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000441	0.00432	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00044	0.00431	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000416	0.00408	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000385	0.00377	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000361	0.00354	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000358	0.00351	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000329	0.00322	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000327	0.00321	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00031	0.00304	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000287	0.00281	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000248	0.00243	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000245	0.0024	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000245	0.0024	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000244	0.00239	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000243	0.00238	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000233	0.00229	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000231	0.00227	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000229	0.00225	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000198	0.00194	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000198	0.00194	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000186	0.00182	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000182	0.00178	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000171	0.00168	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000153	0.00149	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000141	0.00139	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000141	0.00138	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000137	0.00134	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000129	0.00126	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000128	0.00125	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000109	0.00107	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.21e-05	0.000903	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	8.43e-05	0.000826	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.4e-05	0.000823	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.32e-05	0.000815	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.21e-05	0.000805	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.77e-05	0.000761	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.65e-05	0.000749	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.79e-05	0.000666	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.31e-05	0.000619	CbGpPWpGaD
